Jiang VC - Search Results

1

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.

Jiang VC, Liu Y, Lian J, Huang S, Jordan A, Cai Q, Lin R, Yan F, McIntosh J, Li Y, Che Y, Chen Z, Vargas J, Badillo M, Bigcal JN, Lee HH, Wang W, Yao Y, Nie L, Flowers CR, Wang M. Jiang VC, et al. J Clin Invest. 2023 Feb 1;133(3):e165694. doi: 10.1172/JCI165694. J Clin Invest. 2023. PMID: 36719376 Free PMC article.

2

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2.

Wu W, Wang W, Franzen CA, Guo H, Lee J, Li Y, Sukhanova M, Sheng D, Venkataraman G, Ming M, Lu P, Gao A, Xia C, Li J, Zhang LL, Jiang VC, Wang ML, Andrade J, Zhou X, Wang YL. Wu W, et al. Among authors: jiang vc. Blood Adv. 2021 Jan 12;5(1):185-197. doi: 10.1182/bloodadvances.2020001665. Blood Adv. 2021. PMID: 33570628 Free PMC article.

3

Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.

Zhang S, Jiang VC, Han G, Hao D, Lian J, Liu Y, Zhang R, McIntosh J, Wang R, Dang M, Dai E, Wang Y, Santos D, Badillo M, Leeming A, Chen Z, Hartig K, Bigcal J, Zhou J, Kanagal-Shamanna R, Ok CY, Lee H, Steiner RE, Zhang J, Song X, Nair R, Ahmed S, Rodriquez A, Thirumurthi S, Jain P, Wagner-Bartak N, Hill H, Nomie K, Flowers C, Futreal A, Wang L, Wang M. Zhang S, et al. Among authors: jiang vc. Nat Commun. 2021 May 17;12(1):2877. doi: 10.1038/s41467-021-22872-z. Nat Commun. 2021. PMID: 34001881 Free PMC article.

4

The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma.

Jiang VC, Liu Y, Jordan A, McIntosh J, Li Y, Che Y, Jessen KA, Lannutti BJ, Wang M. Jiang VC, et al. J Hematol Oncol. 2021 Aug 28;14(1):132. doi: 10.1186/s13045-021-01143-w. J Hematol Oncol. 2021. PMID: 34454548 Free PMC article.

5

Dual targeting of PI3K and BCL-2 overcomes ibrutinib resistance in aggressive mantle cell lymphoma.

Ye H, Huang S, Liu Y, Chen Z, Wang M, Jiang VC. Ye H, et al. Among authors: jiang vc. J Cell Mol Med. 2022 May;26(10):3068-3073. doi: 10.1111/jcmm.17297. Epub 2022 Mar 30. J Cell Mol Med. 2022. PMID: 35352453 Free PMC article.

6

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma.

Jiang VC, Liu Y, Jordan A, Leeming A, McIntosh J, Huang S, Zhang R, Cai Q, Chen Z, Li Y, Che Y, Nie L, Karlsson I, Mårtensson L, Kovacek M, Teige I, Frendéus B, Wang M. Jiang VC, et al. J Hematol Oncol. 2022 Apr 11;15(1):42. doi: 10.1186/s13045-022-01257-9. J Hematol Oncol. 2022. PMID: 35410313 Free PMC article.

7

PIK-75 overcomes venetoclax resistance via blocking PI3K-AKT signaling and MCL-1 expression in mantle cell lymphoma.

Huang S, Liu Y, Chen Z, Wang M, Jiang VC. Huang S, et al. Among authors: jiang vc. Am J Cancer Res. 2022 Mar 15;12(3):1102-1115. eCollection 2022. Am J Cancer Res. 2022. PMID: 35411248 Free PMC article.

8

TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.

Jiang VC, Hao D, Jain P, Li Y, Cai Q, Yao Y, Nie L, Liu Y, Jin J, Wang W, Lee HH, Che Y, Dai E, Han G, Wang R, Rai K, Futreal A, Flowers C, Wang L, Wang M. Jiang VC, et al. Mol Cancer. 2022 Sep 26;21(1):185. doi: 10.1186/s12943-022-01655-0. Mol Cancer. 2022. PMID: 36163179 Free PMC article.

9

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma.

Li L, Nie L, Jordan A, Cai Q, Liu Y, Li Y, Che Y, Vargas J, Chen Z, Leeming A, Wang W, Yao Y, Wang M, Jiang VC. Li L, et al. Among authors: jiang vc. Haematologica. 2023 Jun 1;108(6):1616-1627. doi: 10.3324/haematol.2022.281538. Haematologica. 2023. PMID: 36420799 Free PMC article.

10

Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma.

Liu Y, Yan F, Jiang VC, Li Y, Che Y, McIntosh J, Jordan A, Hou I, Nie L, Jin J, Wang W, Lee HH, Yao Y, Wang M. Liu Y, et al. Among authors: jiang vc. Haematologica. 2023 May 1;108(5):1412-1416. doi: 10.3324/haematol.2022.282031. Haematologica. 2023. PMID: 36475521 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page